Cortical microinfarcts are the most widespread form of brain infarction but frequently remain undetected by standard neuroimaging protocols. Moreover, microinfarcts are only partially detectable in hematoxylin-eosin-stained (H&E) 4-10 µm paraffin sections at routine neuropathological examination. In this short report, we provide two staining protocols for visualizing cortical microinfarcts in 100-300 µm sections. For low-power microscopy, the first protocol combines aldehyde fuchsine staining for detection of lipofuscin granules and macrophages with Darrow red counterstaining for Nissl material. The second protocol combines collagen IV immunohistochemistry with aldehyde fuchsine/Darrow red or with erythrosin-phosphotungstic acid-aniline blue staining for detailed study of the capillary network. In the first protocol, microinfarcts are recognizable as radially-oriented funnel-like accumulations of aldehyde fuchsine-positive macrophages. The second protocol recognizes microinfarcts and alterations of the capillary network, at whose center accumulations of dead neurons and aldehyde fuchsine-positive macrophages cluster. In addition, the second protocol permits visualization of abnormalities within the capillary network associated with more recent microinfarcts. Both protocols can be useful for comparing MRI datasets with cortical microinfarcts in corresponding whole brain sections of 100-300 µm thickness.
Introduction
Cortical microinfarcts are probably the single most widespread form of brain infarction. However, they can escape detection in standard in vivo magnetic resonance imaging (MRI) protocols, [1] [2] [3] [4] and they are only partially detectable in hematoxylineosin (H&E) stained 4-10 µm paraffin sections. The lesions are described as illdefined foci with neuronal loss, gliosis, and cortical pallour, 5, 6 their reported diameters varying from 50 µm to several millimeters. 7 They can be surrounded by glial cells and/or macrophages. 1 The burden of cortical microinfarcts is underestimated, 3 and the pathomechanisms underlying their development are incompletely understood. 8, 9 Rather surprisingly, there have been few prior attempts to develop novel staining or immunolabeling techniques for cortical microinfarcts in humans. 1 For instance, one recent protocol used thick (40 µm) paraffin-embedded sections and recommended a combination of heat (microwave, steamer) followed by enzymatic digestion (pepsin) to obtain successful collagen IV immunostaining (immunofluorescence) results of the microvasculature in formaldehyde-fixed human brain tissue; 10 but the authors did not examine/apply this method to cortical microinfarcts. Clearly, both autopsy-and MRI-based studies will be needed, going forward, to determine the exact histopathology of these lesions.
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Materials and Methods
All procedures complied with the University of Ulm's ethics committee guidelines and with German law governing usage of human post-mortem tissue. Two autopsy brains (2 males, 68 and 74 years of age) fixed for 14 days by immersion in a 4% aqueous solution of formaldehyde were used. Tissue blocks embedded in polyethylene glycol (PEG 1000, Merck, Carl Roth Ltd, Karlsruhe, Germany) 11, 12 were coronally sectioned on a tetrander (Jung, Heidelberg, Germany) at 100-300 µm as previously described. 13, 14 If paraffin-embedding is preferred, the two staining protocols provided below can be applied to sections of 70-100 µm thickness. 15 Histologic sections were viewed and assessed with an Olympus BX61 microscope (Olympus Optical, Tokyo, Japan). Digital micrographs were taken with an Olympus XC50 camera using the Cell DÒ Imaging Software (Olympus, Münster, Germany). The program's Extended Focal Imaging (EFI) function was used (Figure 1 d,f) to fuse stacks of four differently focused single images into one sharply focused image.
Protocol I -screening for cortical microinfarcts
To provide an overview of cortical microinfarcts for research purposes rather than for routine neuropathology in brain tissue blocks (Figure 2a) , we used free-floating sections of 300 µm thickness. Whereas sections of this thickness are not sufficiently penetrated by all commercially available antibodies, they are ideal here for aldehyde fuchsine staining, which selectively visualizes intraneuronal and extraneuronal lipofuscin as well as CD68-positive macrophages in brain tissue. If desired, counterstaining for Nissl material with Darrow red can be performed (Figure 2b) . 13 
Protocol II -for detailed study of cortical microinfarcts
For additional study purposes, regions of interest from the same PEG blocks as in the prior protocol can be sectioned at 100 µm. In this instance, visualization of the cortical capillary network in and around microinfarcts is best achieved using immunoreactions against collagen IV (Figure 1 c-f) . 10, 16, 17 The primary antibody used below displays robust immunoreactivity in archival fixed brain tissue stored in formaldehyde solutions and achieves optimal penetration of free-floating sections at all optical planes during low-power microscopy. 16, 17 Recently, collagen IV immunohistochemistry was successfully applied to 40 µm paraffin sections by Decker et al. 10 Here, we combined the collagen IV immunoreaction with aldehyde fuchsine staining (with or without Darrow red) or in combination with staining of vessel wall components vessel wall in 100 µm PEG sections (Figure 1 c,d 
Results and Discussion
In protocol I, microinfarcts are recognizable as funnel-like entities that contain radially-oriented accumulations of aldehyde fuchsine-positive macrophages (Figures 1  a,b and 2b) . Protocol II stains not only the microinfarcts but also the affected capillary network, at whose center accumulations of dead neurons and aldehyde fuchsine-positive macrophages cluster (Figure 1c) . Very early puckering within the capillary network may indicate recent microinfarcts (Figure 1e) where very little proliferation of aldehyde fuchsine-positive macrophages was observed at the center of such lesions (Figure 1f ) in contrast to the dense accumulations of macrophages seen in other infarctions (Figure 1 c,d ). Pigment-Nissl staining, which combines aldehyde fuchsine for selective demonstration of neuronal lossextraneuronal remnants of lipofuscin indicate the positions of dead nerve cells -with a Nissl stain (e.g., Darrow red) for topographical overview in the human brain (Figure 2a) , has been in use for many years. 13, 18, 19 However, this stain has not been previously employed to visualize cortical microinfarcts. Here, aldehyde fuchsine effectively stained macrophages in human Technical Note brain tissue (Figure 2b ) and, thus, it can be used instead of CD68 immunoreactions ( Figure 3) . Here, we also combined pigment-Nissl staining with a sensitive immunoreaction (collagen IV) 10 that also renders possible study of cortical microinfarcts with high spatial resolution (Figure 1  c-f) . A drawback of both protocols is that they were performed on unconventionally large and thick free-floating tissue sections (≥100 µm), which, although suitable for research purposes, are not amenable to the demands of routine histopathology laboratories that rely on standard embedding cassettes and automated stainers. For this reason, we previously adapted our tissue processing procedures to also make possible the use of 70-100 µm paraffin-embedded free-floating sections, 15 a method that has been employed successfully elsewhere. 20, 21 Current non-invasive in vivo MRI protocols are constantly undergoing improvement to diagnose and treat patients with cerebrovascular changes. While having attained greater importance in the daily clinical routine, such protocols need interpretation. In particular, efforts are in progress to relate in vivo MRI results directly to histopathological results won from post-mortem study of brains with cortical microinfarcts. 2 Our staining protocols (Figures 1 and 2 a,b) represent an improvement of and an alternative to current methods in thin H&E as well as CD68 sections (Figures 2 c-e and 3 a-c) , and we plan to apply them to compare in vivo MRI datasets with neuropathology of cortical microinfarcts in corresponding 100-300 µm serial whole brain sections. 
